Photo by nci from unsplash
To assess whether moderate‐to‐severe CKD is a treatment modifier for benefit or harm in patients randomly allocated to 24‐month versus 6‐month DAPT. Click to show full abstract
To assess whether moderate‐to‐severe CKD is a treatment modifier for benefit or harm in patients randomly allocated to 24‐month versus 6‐month DAPT.
Keywords:
chronic kidney;
month dapt;
impact chronic;
month;
disease year;
kidney disease
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!